ATHIRA PHARMA INC. -
0.6200
26-November-24 16:45:00
15 minutes delayed
Stocks
-0.0075
-1.20%
Today's range
0.6110 - 0.6390
ISIN
N/A
Source
NASDAQ
-
Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates
07 Nov 2024 16:05:02 By Nasdaq GlobeNewswire
-
22 Oct 2024 07:00:00 By Nasdaq GlobeNewswire
-
Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases
17 Sep 2024 09:00:00 By Nasdaq GlobeNewswire
-
03 Sep 2024 16:01:00 By Nasdaq GlobeNewswire
-
Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates
01 Aug 2024 16:05:00 By Nasdaq GlobeNewswire
-
09 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
12 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
11 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
Athira Pharma to Participate in Upcoming June Conferences
29 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action
17 May 2024 17:00:00 By Nasdaq GlobeNewswire
-
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
15 May 2024 16:05:00 By Nasdaq GlobeNewswire
-
Athira Pharma to Participate in Upcoming May Conferences
02 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
15 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
11 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
03 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
22 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
08 Feb 2024 16:02:00 By Nasdaq GlobeNewswire
-
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
08 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >